Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Irma E. Palazzo"'
Publikováno v:
Hematology Reports, Vol 3, Iss 3, Pp e23-e23 (2011)
Treatment related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia (t-AML) are well known complications after chemotherapy for various hematologic and non-hematologic malignancies. Alkylating agents and Topoisomerase inhibitors are most wi
Externí odkaz:
https://doaj.org/article/eafb18ef861f43dc8be0a21f474ac3ab
Autor:
Roberta E. Smith, Mary Ellen Martin, Deline DaCosta, Raghava Levaka Veera, Irma E. Palazzo, Congli Wang
Publikováno v:
Journal of Hematopathology. 7:79-83
Subcutaneous Sweet’s syndrome (SS) is a rare variant of classic SS characterized by a neutrophilic infiltrate exclusively or predominantly in the subcutaneous tissue, with minimal or absent dermal involvement. We report the case of a patient with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9ac650225abab0cf8b6a204dd936d8b
https://doi.org/10.1007/s12308-014-0206-3
https://doi.org/10.1007/s12308-014-0206-3
Publikováno v:
Journal of Blood Disorders & Transfusion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b0769fb1d371e6a6d3201d19d09453d
https://doi.org/10.4172/2155-9864.1000230
https://doi.org/10.4172/2155-9864.1000230
Publikováno v:
Hematology Reports, Vol 3, Iss 3, Pp e23-e23 (2011)
Hematology Reports
Hematology Reports
Treatment related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia (t-AML) are well known complications after chemotherapy for various hematologic and non-hematologic malignancies. Alkylating agents and Topoisomerase inhibitors are most wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e582fd0ad9315e914c39e7368baf5532
http://www.pagepress.org/journals/index.php/hr/article/view/3289
http://www.pagepress.org/journals/index.php/hr/article/view/3289
Autor:
Lori J. Goldstein, William C. Wood, Hossein Borghaei, R. Katherine Alpaugh, Janice P. Dutcher, Usha Venkatraj, Irma E. Palazzo, Patricia Bernardo, Louis M. Weiner
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 30(4)
2B1 is a bispecific murine monoclonal antibody that binds to the extracellular domains of HER2/neu and FcgammaRIII. 2B1 efficiently promotes the lysis of tumor cells overexpressing HER2/neu by natural killer cells and mononuclear phagocytes that expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f82dd9f0c7bb2d758ce09320eb002d5
https://pubmed.ncbi.nlm.nih.gov/17457220
https://pubmed.ncbi.nlm.nih.gov/17457220